Cachet Pharmaceutical Co., Ltd.

Symbol: 002462.SZ

SHZ

12.28

CNY

Market price today

  • 14.8103

    P/E Ratio

  • 0.8238

    PEG Ratio

  • 3.58B

    MRK Cap

  • 0.02%

    DIV Yield

Cachet Pharmaceutical Co., Ltd. (002462-SZ) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.06%

Operating Profit Margin

0.02%

Net Profit Margin

0.01%

Return on Assets

0.02%

Return on Equity

0.06%

Return on Capital Employed

0.09%

Company general description and statistics

Sector: Healthcare
Industry: Pharmaceuticals - Retailers
CEO:Mr. Yibin Huang
Full-time employees:2294
City:Beijing
Address:Building 1
IPO:2010-08-18
CIK:

Cachet Pharmaceutical Co., Ltd. engages in the wholesale and retail sale of pharmaceutical products in China. It is involved in the supply of medicines to hospitals; wholesale of biological products, medical instruments, and traditional Chinese medicines; pharmaceutical logistic operations; and manufacture of medicines. The company owns 150 chain stores in Beijing that sell medicines, health care foods, medical instruments, cosmetics, daily necessities, and traditional Chinese medicines. Cachet Pharmaceutical Co., Ltd. was founded in 1998 and is based in Beijing, China.

General Outlook

When we look at how much money they make before expenses, they keep 0.063% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.019%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.008%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.016% return, is a testament to Cachet Pharmaceutical Co., Ltd.'s adeptness in optimizing resource deployment. Cachet Pharmaceutical Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.061%. Furthermore, the proficiency of Cachet Pharmaceutical Co., Ltd. in capital utilization is underscored by a remarkable 0.090% return on capital employed.

Stock Prices

Cachet Pharmaceutical Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $12.77, while its low point bottomed out at $12.5. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Cachet Pharmaceutical Co., Ltd.'s stock market.

Liquidity Ratios

Analyzing 002462.SZ liquidity ratios reveals its financial health of the firm. The current ratio of 150.93% gauges short-term asset coverage for liabilities. The quick ratio (122.51%) assesses immediate liquidity, while the cash ratio (29.43%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio150.93%
Quick Ratio122.51%
Cash Ratio29.43%

Profitability Ratios

002462.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 1.90% underscores its earnings before tax deductions. The effective tax rate stands at 32.14%, revealing its tax efficiency. The net income per EBT, 44.16%, and the EBT per EBIT, 101.81%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 1.87%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin1.90%
Effective Tax Rate32.14%
Net Income per EBT44.16%
EBT per EBIT101.81%
EBIT per Revenue1.87%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.51, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding123
Days of Inventory Outstanding33
Operating Cycle140.57
Days of Payables Outstanding72
Cash Conversion Cycle69
Receivables Turnover3.40
Payables Turnover5.08
Inventory Turnover10.99
Fixed Asset Turnover47.29
Asset Turnover1.91

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 4.01, and free cash flow per share, 3.33, depict cash generation on a per-share basis. The cash per share value, 9.78, showcases liquidity position. A payout ratio of 0.80 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.04, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share4.01
Free Cash Flow per Share3.33
Cash per Share9.78
Payout Ratio0.80
Operating Cash Flow Sales Ratio0.04
Free Cash Flow to Operating Cash Flow Ratio0.83
Cash Flow Coverage Ratio0.35
Short Term Coverage Ratio0.37
Capital Expenditure Coverage Ratio5.91
Dividend Paid and Capex Coverage Ratio2.89
Dividend Payout Ratio0.05

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 20.59%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.77, we discern the balance between debt and equity financing. The long-term debt to capitalization, 4.11%, and total debt to capitalization, 43.41%, ratios shed light on its capital structure. An interest coverage of 7.76 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio20.59%
Debt Equity Ratio0.77
Long Term Debt to Capitalization4.11%
Total Debt to Capitalization43.41%
Interest Coverage7.76
Cash Flow to Debt Ratio0.35
Company Equity Multiplier3.73

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 103.16, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.86, reflects the portion of profit attributed to each share. The book value per share, 14.58, represents the net asset value distributed per share, while the tangible book value per share, 19.19, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share103.16
Net Income Per Share0.86
Book Value Per Share14.58
Tangible Book Value Per Share19.19
Shareholders Equity Per Share14.58
Interest Debt Per Share14.36
Capex Per Share-0.69

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 14.40%, indicates top-line expansion, while the gross profit growth, -6.16%, reveals profitability trends. EBIT growth, -40.62%, and operating income growth, -40.62%, offer insights into operational profitability progression. The net income growth, -46.60%, showcases bottom-line expansion, and the EPS growth, -46.58%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth14.40%
Gross Profit Growth-6.16%
EBIT Growth-40.62%
Operating Income Growth-40.62%
Net Income Growth-46.60%
EPS Growth-46.58%
EPS Diluted Growth-46.58%
Weighted Average Shares Growth-0.32%
Weighted Average Shares Diluted Growth-0.32%
Dividends per Share Growth-23.83%
Operating Cash Flow Growth1076.11%
Free Cash Flow Growth496.65%
10-Year Revenue Growth per Share601.63%
5-Year Revenue Growth per Share43.66%
3-Year Revenue Growth per Share29.40%
10-Year Operating CF Growth per Share523.39%
5-Year Operating CF Growth per Share570.36%
3-Year Operating CF Growth per Share43.57%
10-Year Net Income Growth per Share59.26%
5-Year Net Income Growth per Share-34.35%
3-Year Net Income Growth per Share-57.54%
10-Year Shareholders Equity Growth per Share196.23%
5-Year Shareholders Equity Growth per Share46.06%
3-Year Shareholders Equity Growth per Share17.23%
10-Year Dividend per Share Growth per Share441.37%
5-Year Dividend per Share Growth per Share-17.59%
3-Year Dividend per Share Growth per Share-25.62%
Receivables Growth-7.65%
Inventory Growth-4.85%
Asset Growth3.41%
Book Value per Share Growth4.32%
Debt Growth-6.03%
SGA Expenses Growth-11.74%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 5,265,032,426.9, captures the company's total value, considering both debt and equity. Income quality, 4.24, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 2.99%, indicates the value of non-physical assets, and capex to operating cash flow, -12.49%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value5,265,032,426.9
Income Quality4.24
Intangibles to Total Assets2.99%
Capex to Operating Cash Flow-12.49%
Capex to Revenue-0.66%
Capex to Depreciation-98.59%
Graham Number16.80
Return on Tangible Assets1.51%
Graham Net Net0.10
Working Capital4,781,443,151
Tangible Asset Value5,580,072,774
Net Current Asset Value4,601,196,321
Invested Capital1
Average Receivables9,567,688,299
Average Payables5,588,799,984
Average Inventory2,626,987,073
Days Sales Outstanding112
Days Payables Outstanding76
Days of Inventory On Hand33
ROIC4.57%
ROE0.06%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.88, and the price to book ratio, 0.88, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.12, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 3.93, and price to operating cash flows, 3.27, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.88
Price to Book Ratio0.88
Price to Sales Ratio0.12
Price Cash Flow Ratio3.27
Price Earnings to Growth Ratio0.82
Enterprise Value Multiple3.71
Price Fair Value0.88
Price to Operating Cash Flow Ratio3.27
Price to Free Cash Flows Ratio3.93
Price to Tangible Book Ratio0.97
Enterprise Value to Sales0.18
Enterprise Value Over EBITDA4.71
EV to Operating Cash Flow3.30
Earnings Yield6.05%
Free Cash Flow Yield33.79%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Cachet Pharmaceutical Co., Ltd. (002462.SZ) on the SHZ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 14.810 in 2024.

What is the ticker symbol of Cachet Pharmaceutical Co., Ltd. stock?

The ticker symbol of Cachet Pharmaceutical Co., Ltd. stock is 002462.SZ.

What is company IPO date?

IPO date of Cachet Pharmaceutical Co., Ltd. is 2010-08-18.

What is company current share price?

Current share price is 12.280 CNY.

What is stock market cap today?

The market cap of stock today is 3582161960.000.

What is PEG ratio in 2024?

The current 0.824 is 0.824 in 2024.

What is the number of employees in 2024?

In 2024 the company has 2294.